Company Filing History:
2 out of 168 
2 out of 11 
1 out of 3 Years Active: 2015-2019
Title: Chris Low: Innovator in Immunogenic Compositions
Introduction
Chris Low is a notable inventor based in Midlothian, GB. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of two patents to his name, Low's work focuses on developing immunogenic compositions that target specific pathogens.
Latest Patents
Chris Low's latest patents include "Immunogenic compositions containing H7 flagella and methods of use thereof" and "Immunogenic compositions containing O157:H7 flagella including fusion proteins and methods using the immunogenic compositions." These patents disclose methods for inducing an immune response in animals to O157:H7 flagella. The goal is to prevent colonization by O157:H7 in the animal or reduce the amount of O157:H7 infecting the animal. The immune compositions developed by Low aim to prevent or reduce the attachment of O157:H7 to cells within the animal.
Career Highlights
Throughout his career, Chris Low has worked with esteemed institutions such as the University of Edinburgh and Moredun Research Institute. His research has contributed to advancements in immunology and has the potential to impact animal health significantly.
Collaborations
Some of Chris Low's notable coworkers include David Gally and Tom Nathan McNeilly. Their collaborative efforts have furthered research in the field of immunogenic compositions.
Conclusion
Chris Low's innovative work in immunogenic compositions showcases his dedication to advancing scientific knowledge and improving animal health. His patents reflect a commitment to developing effective solutions against specific pathogens.